LGL Group (NYSEAMERICAN:LGL) Rating Increased to Hold at Zacks Research

LGL Group (NYSEAMERICAN:LGL) was upgraded by equities research analysts at Zacks Research to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

LGL Group Trading Down 2.1%

Shares of LGL Group stock opened at $7.00 on Thursday. The stock has a 50 day moving average of $7.14 and a 200 day moving average of $6.58. LGL Group has a 12 month low of $5.45 and a 12 month high of $9.74. The firm has a market cap of $45.78 million, a PE ratio of 63.64 and a beta of 0.31.

LGL Group (NYSEAMERICAN:LGL) last announced its quarterly earnings results on Monday, March 30th. The industrial products company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.09). LGL Group had a net margin of 16.50% and a return on equity of 1.62%. The firm had revenue of $0.80 million for the quarter, compared to the consensus estimate of $9.10 million. As a group, equities research analysts forecast that LGL Group will post 0.06 earnings per share for the current fiscal year.

Hedge Funds Weigh In On LGL Group

An institutional investor recently raised its position in LGL Group stock. Osaic Holdings Inc. boosted its position in shares of LGL Group, Inc. (The) (NYSEAMERICAN:LGL) by 15.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,250 shares of the industrial products company’s stock after buying an additional 2,710 shares during the period. Osaic Holdings Inc. owned approximately 0.38% of LGL Group worth $154,000 as of its most recent SEC filing. 30.28% of the stock is owned by institutional investors.

Key Stories Impacting LGL Group

Here are the key news stories impacting LGL Group this week:

• Positive Sentiment: Sidoti’s forecasts imply LGL Group should stay in the black over the coming quarters, which can support the stock if investors view the earnings outlook as stable and improving.
• Neutral Sentiment: The new research note provides updated EPS estimates for multiple quarters in 2026 and 2027, giving investors a clearer view of expected performance. LGL Group stock information
• Negative Sentiment: The earnings outlook remains fairly small in absolute terms, which may limit enthusiasm for the stock, especially after LGL recently missed quarterly profit and revenue expectations.

LGL Group Company Profile

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.